In today's world I really don't know that any research institution can be certain if Federal grants, or other funding will come as planned, or if it will be delayed, or completely denied. UCLA is not different from others, some of the money they anticipate from the govt. is probably in limbo.
That stated, and NWBO not wanting to sponsor new trials at this time, still the desire to go further with DCVax-L is almost certainly encouraging Dr. Liau to find a way to get it done. Hopefully it won't be that much longer before NWBO gains approval, while that doesn't immediately bring in revenue, it should bring much higher share prices, and yes dilution will still be required, but a million shares will bring in many times the dollars it previously did. I believe that NWBO will be willing to help with trial costs.
Hopefully the Govt. will realize that money spent on research now will often result in income later as products are approved. It's not immediate, NWBO no doubt has years of solid earnings where prior costs offset taxes, but eventually they'll be paying taxes as well. Of course all whose salaries are paid by DCVax-L sales will be generating tax income to the govt as well.
No doubt, there are places where the Govt. has waste and could spend their money more wisely. I don't believe that money spent on drug development doesn't pay off for the govt. in the long run. Without them, new products will still be developed, but it will take longer, and that puts off the time that it takes to pay off in new taxes paid to the Govt.
Gary
Market Data 
Markets 
AI
